Phacilitate Match

Phacilitate Match was developed as an on-site event tool geared towards biotech companies who were looking to meet with potential partners. But why limit this to live event matchmaking? In the current climate, we believe that there is no better time for biotech companies to focus on relationship building, and creating connections for both current and future needs.
How does virtual Phacilitate Match work?

- Once you have signed up for virtual Phacilitate Match, you will be contacted by Amanda Kendall, Head of Community here at Phacilitate
- Amanda will ask some profiling questions to understand what suppliers you’re aiming to connect with
- Amanda will present you with organisations that match your needs, from which you can select your priority connections
- Virtual meetings will be arranged on your behalf

By signing up for Phacilitate Match, you will be taking part in a free bespoke service that is completely unique to you. So if you are part of a biotech looking for new contacts, get in touch to see how we can help your company build valuable, lasting connections.
PARTICIPATING COMPANIES
ImmTune Therapies

ImmTune Therapies

ImmTune therapies is pioneering the development of an off-the-shelf injectable cell therapy platform which re-engineers patient’s immune cells inside their bodies to treat disease. Our first product which will engineer immune cells to express a chimeric antigen receptor (CAR) which binds specific antigens on cancer cells and activates the T-cells to destroy them. Our in vivo process produces more potent, and cheaper therapies, accessible to a wider patient population across different diseases.

FIND OUT MORE
LIfT Biosciences

LIfT Biosciences

LIfT Biosciences is a UK-based biotech company bringing to market a 1st in class allogeneic innate cell therapy called Neutrophil Only Leukocyte Infusion Therapy (N-LIfT). N-LIfT has the game-changing potential to destroy all solid tumours irrespective of mutation or strain. N-LIfT uses a special type of N1a neutrophil with special cancer killing and immune recruitment capabilities. LIfT BioSciences was founded by Alex Blyth following the death of his mother to pancreatic cancer. LIfT Biosciences is backed by a strong network of investors including venture capital firms Kizoo Technology, Downing Ventures and entrepreneur Jonathan Milner.

FIND OUT MORE

SIGN UP HERE

PREVIOUSLY PARTICIPATING COMPANIES